A new study conducted by public health researchers at the University of North Carolina and the North Carolina Department of Health and Human Services uncovered new information on the efficacy of Pfizer's COVID-19 vaccine in young people age 5 to 11.
"Our estimate suggests an expected net harm from boosters in this young adult age group, whereby the negative outcomes of all severe adverse events and hospitalizations may on average outweigh the expected benefits in terms of Covid-19 hospitalizations averted," say study authors from Oxford, Harvard, and Johns Hopkins.
Republican Florida Gov. Ron DeSantis overviewed several major policy victories during a Sunday speech at the National Conservatism Conference in Miami, Florida, emphasizing his...
In early September, the U.S. Department of Justice (DOJ) announced that pharma giant Bayer would have to fork over millions to the DOJ to resolve allegations of fraud under the False Claims Act (FCA).